Palvella Therapeutics, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Palvella Therapeutics, Inc. (PVLA) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of -$904 as of 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2014-11-13
- 2014-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$904.00.
- 2014-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $10.01K.
- 2014-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$4.78K.
- 2013-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$3.23K.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2014-09-30 | -$904.00 10-Q · filed 2014-11-13 |
| 2014-06-30 | $10.01K 10-Q · filed 2014-11-13 |
| 2014-03-31 | -$4.78K 10-Q · filed 2014-06-02 |
| 2013-12-31 | -$3.23K 10-Q · filed 2014-05-14 |
| 2013-06-30 | $4.73K 10-K · filed 2014-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |